Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a Phase I open-label dose escalation study
- 27 November 2000
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 36 (7), 2132-2139
- https://doi.org/10.1016/s0735-1097(00)00988-8
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Expression of the Angiogenic Protein, Platelet-Derived Endothelial Cell Growth Factor, in Coronary Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Modulation of myocardial perfusion and vascular reactivity by pericardial basic fibroblast growth factor: Insight into ischemia-induced reduction in endothelium-dependent vasodilatationThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Arterial gene therapyThe Lancet, 1996
- Echo Planar MRI of the Heart on a Standard System: Validation of Measurements of Left Ventricular Function and MassJournal of Computer Assisted Tomography, 1996
- Heparin Structure and Interactions with Basic Fibroblast Growth FactorScience, 1996
- Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injuryMolecular and Cellular Biochemistry, 1995
- Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardiumJournal of the American College of Cardiology, 1993
- Strategy of complete revascularization in patients with multivessel coronary artery disease (a report from the 1985–1986 NHLBI PTCA Registry)The American Journal of Cardiology, 1992
- Hypotensive Activity of Fibroblast Growth FactorScience, 1991
- The effect of complete and incomplete revascularization on exercise variables in patients undergoing coronary angioplastyClinical Cardiology, 1990